Optibiotix Health Share Discussion Threads

[scotty1] 06/7/2018 15:57

Thanks Elrico.

[joyjoy13] 06/7/2018 15:57

Nice find Parsnip! 👍

[m4rtinu] 06/7/2018 15:52

Shame it is Friday. The weekend has come at the wrong time for a continued share price rise. Hopefully momentum will continue on Monday.

[elrico] 06/7/2018 15:52

Not as interesting as your, Parsnip.....she may well be! ;)

[elrico] 06/7/2018 15:51

You have mail Scotty.

[scotty1] 06/7/2018 15:47

Good he may get it right on HSR then 🤔

[slartybartfaster] 06/7/2018 15:41

Thanks for showing yourself mike. I knew you were a goodun really. lol

[primal123] 06/7/2018 15:36

Elric has informed TW he has the wrong person mentioned in his bearcast

[scotty1] 06/7/2018 15:30

Thanks primal,just mailed him to also put it on HSR seeing as it's a tip on there and subscribers shouldn't have to pay again to listen to what he as to say,So he's going to do an update on there later,will have a look and see then.

[someuwin] 06/7/2018 15:28

Small but +Ve mention in IC today.

[primal123] 06/7/2018 15:25

All I know is he is giving info on the RNS today but he has the wrong Mike Mcgeever. TW is an absolute idiot, he just says things and doesn't know anything !

[parsnip1] 06/7/2018 15:24

Looks an interesting guy lol.

[primal123] 06/7/2018 15:13

And can sell above share price at 72.11! Strong!

[belgrano2] 06/7/2018 14:55

Full ask of 73p being paid, and cant buy more than 5k parcels on iii. pace is picking up i'm delighted to see.

[nobbygnome] 06/7/2018 14:44

I was part of that fund raising and all I can say is that I got what I asked for so was not scaled back.

[dire cons] 06/7/2018 14:39

Stephen O'Hara, CEO of OptiBiotix, said: "The Company has received a high level of partner interest in its technology and products across new application areas and territories that have the potential for significant value uplift. It has become clear that new opportunities, particularly the development of LPLDL® into a pharmaceutical product, the high level of corporate interest in SweetBiotix across multiple applications, and the potential for listing a range of Health and Wellbeing products with major retailers are not achievable in the short term within current resources. Rather than delay these opportunities until OptiBiotix has sufficient revenues to cover costs, the Board has decided to take additional funds tocapitalise on these growth opportunities and build shareholder value. Whilst the subscription was oversubscribed the company has limited the funds received to ensure a focus on value creation and has added new institutional investors to the share register."

[shrewdmole] 06/7/2018 14:33

Slarty

Apologies but thought I'd heard or read that it was very over subscribed in this instance.

Stand corrected if I'm wrong.

S

[monkeywench1] 06/7/2018 14:31

Lol keep ramping slartyrampfarter

[brucie5] 06/7/2018 14:10

Delighted with this, since I decided to double up at just over 70 this morning, and was already beginning to regret it...

This time it's different, right?
;)

[riskybusiness1] 06/7/2018 14:08

Penny starting to drop. Great to see proof of accumulation. We knew it was going on but you always have the doubters.

[imnotlong] 06/7/2018 13:48

Ok, will take your word on the chart - it just looks like a wiggly line to me. But let’s hope your chart wisdom finally pays off and we finally get a decent and sustained uplift. News on an American pharma deal should do it.

[parob] 06/7/2018 13:44

I know I keep going on about it but the Inverse Head & Shoulders will be complete by then. I've made a small fortune recently buying in before breakouts by studying the chart with TERN, N4P and now AOR. Inverse H&S is very bullish and you can see how it's formed over the last 10 months on the 1 year chart. Of course there are no guarantees but the chart looks absolutely set up. Plus no options left to be exercised, stacks of good news banked up and more on the way. Technical traders will pile in once we're through 75p and I'm convinced we'll go straight through this time hopefully with news/volume.